SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-24-003515
Filing Date
2024-02-06
Accepted
2024-02-06 17:05:22
Documents
3
Period of Report
2024-02-06

Document Format Files

Seq Description Document Type Size
1 6-K innatepharma6-k262024.htm 6-K 22396
2 EX-1.1 exhibit11-6xk020624.htm EX-1.1 366111
3 EX-5.1 exhibit51-6xk020624.htm EX-5.1 51175
  Complete submission text file 0001628280-24-003515.txt   440854
Mailing Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009
Business Address 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 33430303030
Innate Pharma SA (Filer) CIK: 0001598599 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39084 | Film No.: 24601102
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)